Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase NA 1

Status

Unknown 6Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 63NIH 18UNKNOWN 6OTHER_GOV 3INDUSTRY 3FED 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 5Sarcoma 1

Conditions

Triple Negative Breast Neoplasms 3Breast Neoplasms 3Leiomyosarcoma 1

Interventions

Capecitabine 15Paclitaxel 13S 1 (combination) 9apatinib 8Oxaliplatin 8Carboplatin 8Cisplatin 7pyrotinib 6Epirubicin 6Docetaxel 6sintilimab 5camrelizumab 5anlotinib 5Radiotherapy 5Drug Therapy 5130-nm albumin-bound paclitaxel 5nimotuzumab 4nedaplatin 4Vinorelbine 4Temozolomide 4Irinotecan 4Fulvestrant 4Etoposide 4Bevacizumab 4toripalimab 3titanium silicide 3exemestane 3Trastuzumab 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Epirubicin × Clear all
NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

ChineseAMS

Phase NA Unknown
28 enrolled
Sarcoma

Leiomyosarcoma

NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

ChineseAMS

Phase 2 Unknown
200 enrolled
Breast

Breast Neoplasms

NCT01134523 2013-03-15

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

ChineseAMS

Phase 3 Unknown
1,000 enrolled
Breast

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

ChineseAMS

Phase 3 Unknown
100 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01276769 2011-11-16

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

ChineseAMS

Phase 2 Unknown
80 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡